Mitomycin C Trabeculectomy Trial for Glaucoma in Ethiopia

• Status: Unknown status
• Trial end date: 2019-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is a randomized, double-masked trial to examine the response to trabeculectomy surgery. In this study, patients will be randomized to receive MMC via subconjunctival injection or topical sponge application.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Francis I. Proctor Foundation; University of California, San Francisco
• Collaborator: Menelik II Hospital
• Treatments: Mitomycin; Mitomycins

Criteria

Inclusion Criteria:

• Age >=40

• Planning to have a trabeculectomy

Exclusion Criteria:

• Life threatening or debilitating disease

• Inability to complete necessary exams and/or ocular disease that would preclude assessment of intraocular pressure, visual field, or optic disc

• Pseudophakic lens

• Contralateral eye already enrolled in study